Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus brevis SBC8803 and Improved Atopic Dermatitis Symptoms

Research synthesisVery low evidenceSmall effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial effects on atopic dermatitis symptoms, with effect sizes ranging from small to moderate. The evidence is limited to review articles, and no specific dose, population, or form data were consistently reported.

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated Jul 12, 2026
3 of 3 papers
Back to top